Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

In vitro activity assessment of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., including β-lactam nonsusceptible molecularly characterized isolates, collected from 2020 to 2021 in the United States and European hospitals

Microbiology Spectrum(2024)10.1128/spectrum.01474-24Source: DataRank Database

In vitro activity assessment of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., including β-lactam nonsusceptible molecularly characterized isolates, collected from 2020 to 2021 in the United States and European hospitals is a research paper published in Microbiology Spectrum (2024). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 2.54)OA: goldTopics (58)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Joshua Maher ORCID,Hélio S. Sader ORCID,Mariana Castanheira ORCID,Rodrigo E. Mendes ORCID,John H. Kimbrough ORCID

Live enrichment

PubMed:39387599 OpenAlex:https://openalex.org/W4403303732

Shionogi (Shionogi & Co. Ltd.)

FWCI

2.54

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/spectrum.01474-24

publisherhttps://doi.org/10.1128/spectrum.01474-24

publisherhttps://journals.asm.org/doi/pdf/10.1128/spectrum.01474-24

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39387599

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11537082

Fields of Study

Antibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyAntibiotic Use and ResistanceAnti-Bacterial AgentsPseudomonas aeruginosaMicrobial Sensitivity TestsAcinetobacterUnited StatesEuropeHumansCephalosporinsCefiderocolbeta-LactamasesHospitalsBacterial ProteinsEnterobacteriaceaebeta-LactamsCarbapenemsDrug Resistance, Multiple, Bacterial

MeSH Terms

CefiderocolAcinetobacterAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCephalosporinsEnterobacteriaceaeEuropeHospitalsHumansMicrobial Sensitivity TestsPseudomonas aeruginosaUnited StatesCarbapenemsDrug Resistance, Multiple, Bacterialbeta-Lactams

Keywords

MicrobiologyPseudomonas aeruginosaAcinetobacter baumanniiCephalosporinBiologyAcinetobacter calcoaceticusAntimicrobialCeftazidime/avibactamCarbapenemAcinetobacterImipenemKlebsiella pneumoniaeMeropenemEscherichia coliCeftazidimeAntibiotic resistanceAntibioticsBacteriaGeneGeneticsCREcefiderocolmultidrug resistance